Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 11 December 2012
Vol. 5, Issue 254, p. lc5
[DOI: 10.1126/scisignal.2003734]

LETTERS

Comment on "Epidermal Growth Factor Receptor Is Essential for Toll-Like Receptor 3 Signaling"

Barbara Burtness1,2, Shanthi Marur3, Julie E. Bauman4, Erica A. Golemis2*, Ranee Mehra1,2, and Steven J. Cohen1,2

1 Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
2 Program in Developmental Therapeutics, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
3 Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
4 Department of Hematology and Oncology, University of New Mexico Cancer Center, Albuquerque, NM 87102, USA.

Abstract: Epidermal growth factor receptor (EGFR) and mammalian target of rapamycin (mTOR) play important roles in tumor growth, which has stimulated efforts toward the design of targeted cancer therapeutics that inhibit their function. A growing body of literature indicates that EGFR and mTOR are also essential to support a functional innate immune response. Hence, although combination therapies that block both EGFR and mTOR may have improved activity against tumors, they may also place patients at risk of fulminant infections. We discuss data supporting this hypothesis.

* Corresponding author. E-mail: erica.golemis{at}fccc.edu

Citation: B. Burtness, S. Marur, J. E. Bauman, E. A. Golemis, R. Mehra, S. J. Cohen, Comment on "Epidermal Growth Factor Receptor Is Essential for Toll-Like Receptor 3 Signaling". Sci. Signal. 5, lc5 (2012).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
2012: Signaling Breakthroughs of the Year.
M. B. Yaffe and N. R. Gough (2013)
Science Signaling 6, eg1
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882